Emtricitabine/Tenofovir Disoproxil Fumarate: In Combination with a Protease Inhibitor in HIV-1 Infection

ISSN： 0012-6667

Source： Drugs, Vol.69, Iss.7, 2009-05, pp. : 843-857

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emtricitabine/Tenofovir Disoproxil Fumarate

By Adis International Limited

Drugs in R&D, Vol. 5, Iss. 3, 2004-01 ,pp. : 160-161

Adis International

Access to resources Recommend Favorite

Emtricitabine/Tenofovir Disoproxil Fumarate

By Toni M. Dando Antona J. Wagstaff

Drugs, Vol. 64, Iss. 18, 2004-01 ,pp. : 2075-2082

Adis International

Access to resources Recommend Favorite

A new drug combination therapy for treatment-naive patients with HIV-1 infection, consisting of raltegravir, emtricitabine and tenofovir disoproxil fumarate

By Clercq Erik De

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 17, 2009-12 ,pp. : 2935-2937

Informa Healthcare

Access to resources Recommend Favorite

Use of tenofovir disoproxil fumarate and emtricitabine combination in HIV-infected patients

By Gazzard Brian G

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 793-802

Informa Healthcare

Access to resources Recommend Favorite

Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen: A Guide to Its Use in HIV-1 Infection

By Lyseng-Williamson Katherine A. Scott Lesley J.

Clinical Drug Investigation, Vol. 32, Iss. 10, 2012-10 ,pp. : 715-722

Adis International

Access to resources Recommend Favorite